Synergy Pharmaceuticals – Court Approves DIP Financing on Final Basis, Including Third New Money Tranche of $25mn

February 26, 2019 – The Court hearing the Synergy Pharmaceuticals case issued a final order [Docket No. 454] authorizing the Debtors to access debtor-in-possession (“DIP”) financing of $159.1mn (the “DIP Loans”) which is comprised of (i) approximately $114.1mn of loans representing a partial “roll-up” of prepetition secured obligations and (ii) $45.0mn of “new money” loans…